Claims for Patent: 10,485,851

Summary for Patent: 10,485,851

Title:	Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid
Abstract:	An injectable aqueous solution, the pH of which is from 6.0 to 8.0, having at least: a) human glucagon, and b) a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Hy. In an embodiment, the compositions have, in addition, a gastrointestinal hormone.
Inventor(s):	Geissler; Alexandre (Lyons, FR), Laage; Segolene (Lyons, FR), Charvet; Richard (Rillieux la Pape, FR), Soula; Olivier (Meyzieu, FR), Duracher; David (Lyons, FR), Meiffren; Gregory (Meyzieu, FR)
Assignee:	ADOCIA (Lyons, FR)
Application Number:	15/616,627
Patent Claims:	1. A composition in the form of an injectable aqueous solution, the pH of which is from 6.0 to 8.0, comprising at least: a) human glucagon; b) a co-polyamino acid consisting of glutamic or aspartic units, bearing carboxylate charges and hydrophobic radicals Hy, and said hydrophobic radicals Hy being radicals of the following formula I: *GpR.sub.rGpA.sub.aGpC).sub.p Formula I in which GpR is a radical of formula II or II': ##STR00136## GpA is a radical of formula III or III': ##STR00137## GpC is a radical of formula IV: ##STR00138## the * indicate the sites of attachment of the different groups bound by amide functions; a is a whole number equal to 0 or 1; b is a whole number equal to 0 or 1; p is a whole number equal to 1 or 2, and if p is equal to 1, then a is equal to 0 or 1 and GpA is a radical of formula III', and if p is equal to 2, then a is equal to 1 and GpA is a radical of formula III; c is a whole number equal to 0 or 1, and, if c is equal to 0, then d is equal to 1 or 2; d is a whole number equal to 0, to 1 or 2; r is a whole number equal to 0 or 1, and if r is equal to 0, then the hydrophobic radical of formula I is bound to the co-polyamino acid via a covalent bond between a carbonyl of the hydrophobic radical and a nitrogen atom in the N-terminal position of the co-polyamino acid, thus forming an amide function, and if r is equal to 1, then the hydrophobic radical of formula I is bound to the co-polyamino acid: via a covalent bond between a nitrogen atom of the hydrophobic radical and a carbonyl of the co-polyamino acid therefore forming an amide function originating from the reaction between an amine function of the precursor of the hydrophobic radical and an acid function borne by the precursor of the co-polyamino acid, or via a covalent bond between a carbonyl of the hydrophobic radical and a nitrogen atom in N-terminal position of the co-polyamino acid therefore forming an amide function originating from the reaction of an acid function of the precursor of the hydrophobic radical and an amine function in N terminal position borne by the precursor of the co-polyamino acid; R is a radical selected from the group consisting of: a linear or branched divalent alkyl radical comprising, if GpR is a radical of formula II, from 2 to 12 carbon atoms, or, if GpR is a radical of formula II', from 1 to 11 carbon atoms; a linear or branched divalent alkyl radical comprising, if GpR is a radical of formula II, from 2 to 11 carbon atoms, or, if GpR is a radical of formula II', from 1 to 11 carbon atoms, said alkyl radical bearing one or more --CONH.sub.2 functions, and an unsubstituted ether or polyether radical comprising from 4 to 14 carbon atoms and from 1 to 5 oxygen atoms; A is a linear or branched alkyl radical comprising from 1 to 6 carbon atoms; B is a linear or branched alkyl radical, optionally comprising an aromatic ring, comprising from 1 to 9 carbon atoms; C.sub.x is a linear or branched monovalent alkyl radical, in which x indicates the number of carbon atoms, and: if p is equal to 1, x is from 11 to 25 (11.ltoreq.x.ltoreq.25); if p is equal to 2, x is from 9 to 15 (9.ltoreq.x.ltoreq.15), the ratio i between the number of hydrophobic radicals and the number of glutamic or aspartic units being between 0<i.ltoreq.0.5; when several hydrophobic radicals are borne by a co-polyamino acid, then they are identical or different, the degree of polymerization DP in glutamic or aspartic units is from 10 to 250; the free acid functions being in the form of a salt of an alkaline cation selected from the group consisting of Na.sup.+ and K.sup.+. 2. The composition according to claim 1, wherein said hydrophobic radicals are selected from the hydrophobic radicals of formula I in which p=1, represented by the following formula V: *GpR.sub.rGpA.sub.aGpC formula V wherein GpR, GpA, GpC, r and a have the definitions given above. 3. The composition according to claim 1, wherein said hydrophobic radicals are selected from the hydrophobic radicals of formula I in which a=1 and p=2, represented by the following formula VI: *GpR.sub.rGpAGpC).sub.2 Formula VI wherein GpR, GpA, GpC, r and a have the definitions given above. 4. The composition according to claim 1, wherein the co-polyamino acid bearing carboxylate charges and hydrophobic radicals is selected from the co-polyamino acids of the following formula VII: ##STR00139## in which, D represents, independently, either a --CH.sub.2-- group (aspartic unit) or a --CH.sub.2--CH.sub.2-- group (glutamic unit), Hy is a hydrophobic radical selected from the hydrophobic radicals of formula I, V or VI, in which r=1 and GpR is a radical of Formula II, R.sub.1 is a hydrophobic radical selected from the hydrophobic radicals of formula I, V or VI in which r=0 or r=1 and GpR is a radical of Formula II', or a radical selected from the group consisting of H, a C2 to C10 linear acyl group, a C3 to C10 branched acyl group, benzyl, a terminal "amino acid" unit and a pyroglutamate, R.sub.2 is a hydrophobic radical selected from the hydrophobic radicals of formula I, V or VI in which r=1 and GpR is a radical of Formula II, an --NR'R'' radical, R' and R'' which are identical or different being selected from the group consisting of H, the C2 to C10 linear or branched or cyclic alkyls, benzyl, and said alkyl R' and R'' together optionally forming one or more saturated, unsaturated and/or aromatic carbon rings and/or optionally comprising heteroatoms selected from the group consisting of O, N and S; at least of R.sub.1 or R.sub.2 is a hydrophobic radical as defined above, X represents an H or a cationic entity selected from the group comprising the metal cations; n+m represents the degree of polymerization DP of the co-polyamino acid, that is to say the average number of monomer units per chain and 5.ltoreq.n+m.ltoreq.250. 5. The composition according to claim 4, wherein co-polyamino acid bearing carboxylate charges and hydrophobic charges is selected from the co-polyamino acids of formula VII in which n=0 of the following formula VIIb: ##STR00140## in which m, X, D, R.sub.1 and R.sub.2 have the definitions given above and at least one R.sub.1 or R.sub.2 is a hydrophobic radical of formula I, V or VI. 6. The composition according to claim 5, wherein the co-polyamino acid bearing carboxylate charges and hydrophobic radicals is selected from the co-polyamino acids of formula VIIb in which R.sub.2 is a hydrophobic radical of formula I, V or VI in which r=1 and GpR is of formula II'. 7. The composition according to claim 4, wherein the co-polyamino acid bearing carboxylate charges and hydrophobic radicals is selected from the co-polyamino acids of formula VII, VIIb in which the at least one co-polyamino acid is selected from the co-polyamino acids in which group D is a --CH.sub.2-- group (aspartic unit). 8. The composition according to claim 4, wherein the co-polyamino acid bearing carboxylate charges and hydrophobic radicals is selected from the co-polyamino acids of formulas VII, VIIb in which the at least one co-polyamino acid is selected from the co-polyamino acids in which group D is a group --CH.sub.2--CH.sub.2-- (glutamic unit). 9. The composition according to claim 1, wherein the concentration of co-polyamino acid bearing carboxylate charges and hydrophobic radicals is at most 40 mg/mL. 10. The composition according to claim 1, wherein the concentration of human glucagon is from 0.25 to 5 mg/mL. 11. The composition according to claim 1, wherein the molar ratio [hydrophobic radical]/[human glucagon] is less than 15. 12. The composition according to claim 1, wherein the composition comprises, in addition, a polyanionic compound. 13. The composition according to claim 1, wherein the composition comprises, in addition, a zinc salt. 14. The composition according to claim 1, wherein the composition comprises, in addition, a gastrointestinal hormone. 15. The composition according to claim 14, wherein the gastrointestinal hormone is selected from the group consisting of exenatide, liraglutide, lixisenatide, albiglutide and dulaglutide, their analogs or derivatives and their pharmaceutically acceptable salts thereof. 16. The composition according to claim 14, wherein the concentration of gastrointestinal hormone is within an interval from 0.01 to 10 mg/mL.

Details for Patent 10,485,851

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Glaxosmithkline Llc	TANZEUM	albiglutide	For Injection	125431	04/15/2014		2036-06-07
Eli Lilly And Company	TRULICITY	dulaglutide	Injection	125469	09/18/2014		2036-06-07
Eli Lilly And Company	TRULICITY	dulaglutide	Injection	125469	09/04/2020		2036-06-07
Sanofi-aventis U.s. Llc	ADLYXIN	lixisenatide	Injection	208471	07/27/2016		2036-06-07